BackTibet Rhodiola Pharmaceutical Holding Class A Overview

Tibet Rhodiola Pharmaceutical Holding Class A Current Assets

Track Tibet Rhodiola Pharmaceutical Holding Class A's current assets ($4.9B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$4.90B
↑ 15.96% YoYΔ $673.72M vs prior year quarter

Peer trimmed avg / median

Loading

Tibet Rhodiola Pharmaceutical Holding Class A Current Assets History

Loading

Tibet Rhodiola Pharmaceutical Holding Class A vs. peers: Current Assets Comparison

Loading

Tibet Rhodiola Pharmaceutical Holding Class A Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Tibet Rhodiola Pharmaceutical Holding Class A (600211.SS) FAQ

As of the most recent data (June 2026), 600211.SS shows a current assets of $4.9B. That compares with $4.2B in the prior-year period — up 16.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600211.SS's current assets is now $4.9B (was $4.2B) — a 16.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tibet Rhodiola Pharmaceutical Holding Class A is outperforming or lagging.

Tracking 600211.SS's current assets over time shows whether Tibet Rhodiola Pharmaceutical Holding Class A is scaling, shrinking, or reshaping that part of the business. The current reading is $4.9B That compares with $4.2B in the prior-year period — up 16.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Tibet Rhodiola Pharmaceutical Holding Class A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $4.9B) with ownership activity and broader fundamentals.